5/9/2025

Janusmed sex and gender

Janusmed sex and gender – bicalutamide

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Bicalutamide

Bicalutamide

Class : B

Show all info

Print

Contact us

  1. Physicians' Desk Reference. http://www.pdr.net. [cited 2018-12-17].

  2. Fass.se [cited 2018-12-06].

  3. Müderris II, Bayram F, Ozçelik B, Güven M. New alternative treatment in hirsutism: bicalutamide 25 mg/day. Gynecol Endocrinol. 2002;16(1):63-6.

  4. Moretti C, Guccione L, Di Giacinto P, Simonelli I, Exacoustos C, Toscano V et al. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial. J Clin Endocrinol Metab. 2018;103(3):824-838.

  5. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2018-12-17.]

  1. Physicians' Desk Reference. http://www.pdr.net. [cited 2018-12-17].
  2. Fass.se [cited 2018-12-06].
  3. Müderris II, Bayram F, Ozçelik B, Güven M. New alternative treatment in hirsutism: bicalutamide 25 mg/day. Gynecol Endocrinol. 2002;16(1):63-6.
  4. Moretti C, Guccione L, Di Giacinto P, Simonelli I, Exacoustos C, Toscano V et al. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial. J Clin Endocrinol Metab. 2018;103(3):824-838.
  5. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2018-12-17.]